Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.56
Delayed Data
As of Feb 22
 -0.0234 / -1.48%
Today’s Change
1.47
Today|||52-Week Range
10.90
-10.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues277.0K0.000.000.00
 
 
Depreciation And Amortization24.0K9.0K8.0K8.0K
 
 
 
 
 
 
Operating ExpensesGross Income---9.0K-8.0K-8.0K
 
 
 
 
General Expenses3.4M2.7M2.5M2.1M
 
 
 
 
 
Research And Development1.9M1.3M1.2M950.0K
 
 
 
 
 
Total Operating Expenses3.4M2.7M2.5M2.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-2.7M-2.5M-2.1M
 
 
 
 
 
Other Expenses-86.0K820.0K16.0K6.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.2M-1.9M-2.5M-2.1M
 
 
 
 
 
Income Taxes-410.0K-306.0K-268.0K-219.0K
 
 
 
 
 
Preferred Dividend-50.0K-50.0K-50.0K-7.1M
 
 
 
 
 
Net Income-2.8M-1.6M-2.2M-1.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.3M4.3M4.4M9.8M
 
 
 
 
 
Shares To Calculate EPS Diluted4.3M4.3M4.4M9.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.69-$0.38-$0.50-$0.91
 
 
 
 
 
EPS Diluted-$0.68-$0.38-$0.50-$0.91